Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Fast Track Approved

<< Previous

Bullboard Posts

Next >>

Comment by jicoopon Nov 23, 2020 10:09am

192 Views

Post# 31951705

RE:RE:Fast Track Approved

Eoganacht wrote: Great news! We're now on target to submit an application for accelerated approval one year from the time we treat our 25th patient. If all goes well, end game should be early 2022.

made2last wrote: https://stockhouse.com/news/press-releases/2020/11/23/theralase-granted-fda-fast-track-designation-for-nmibc-phase-ii-clinical-study

So Vegas 2022 may be back on for us you saying ?

So You're Telling Me There's A Chance | Jim Carrey | Know Your Meme